PFBT
EDIT icon

Parkside Financial Bank & Trust’s Editas Medicine EDIT Stock Holding History

Parkside Financial Bank & Trust’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33K Hold
410
– – ﹤0.01% 2320
2026
Q1 		$1.01K Hold
410
– – ﹤0.01% 2352
2025
Q4 		$841 Hold
410
– – ﹤0.01% 2396
2025
Q3 		$1.42K Hold
410
– – ﹤0.01% 2145
2025
Q2 		$902 Buy
+410
New +$671 ﹤0.01% 2302

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Parkside Financial Bank & Trust's EDIT Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Editas Medicine (EDIT) position steady in Q2 2026 at 410 shares worth $1.33K. The position accounts for ﹤0.01% of the portfolio, ranked #2320.

Parkside Financial Bank & Trust first reported a position in EDIT in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.42K in Q3 2025. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Parkside Financial Bank & Trust held 410 shares of Editas Medicine worth $1.33K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2320 holding.
  • Parkside Financial Bank & Trust first reported a position in Editas Medicine in Q2 2025 and has held it in 5 quarters since.
  • Parkside Financial Bank & Trust's Editas Medicine position peaked at $1.42K in Q3 2025.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.